The present disclosure relates generally to heart valve implants, and more particularly, to artificial heart valves custom configured or fitted to repair a particular person's failing heart valve.
A human heart, generally designated in its entirety by the reference character H in
During a diastole phase of each cardiac cycle, the muscles of the heart H relax, and all four chambers expand. As the left ventricle LV expands, pressure in that chamber drops and a mitral valve MV separating the left atrium LA from the left ventricle opens, allowing blood to flow into the left ventricle from the left atrium LA. Similarly, as the right ventricle RV expands, pressure inside that chamber drops and a tricuspid valve TV separating the right atrium RA from the right ventricle opens, allowing blood to flow into the right ventricle from the right atrium. While both ventricles are relaxed shortly before the end of the diastole phase, the atria contract slightly, pushing additional blood into the ventricles.
During a systole phase of each cardiac cycle, muscles of the heart H contract both ventricles. As the left ventricle LV contracts, pressure in that chamber increases, closing the mitral valve MV and forcing oxygen-rich blood though an aortic valve AV at the downstream end of the left ventricle LV. The blood passing through the aortic valve AV enters the aorta AA and travels downstream through arteries that distribute the oxygen-rich blood throughout the body. Similarly, as the right ventricle RV contracts, the tricuspid valve TV closes and blood is forced through a pulmonary valve PV at the downstream end of the right ventricle into the pulmonary artery PA for transport to the lungs. Tendon-like cords called chordae tendineae CT span the left and right ventricles LV, RV, connecting the mitral valve MV and tricuspid valve TV, respectively, to muscle forming the bottom of the corresponding ventricles. The chordae tendineae CT prevent the leaflets of the mitral valve MV and tricuspid valve TV from opening by prolapsing into the corresponding atrium as the ventricles contract. Accordingly, blood is forced through the correspond downstream valves and does not backflow into the atria. Once the ventricles are fully contracted, the diastole phase rebegins and the downstream valves close.
For a variety of reasons, some mitral valves MV and/or tricuspid valves TV leak, allowing blood to flow back through the valve to the corresponding atrium. When blood flows back into either atrium instead of flowing downstream, insufficient blood is pumped downstream. Various replacement valves have been developed to alleviate leakage. Some replacement valves are bioprosthetic, having animal-based leaflets, e.g., harvested bovine or porcine heart valves, mounted in a frame adapted to be implanted in the heart to replace the leaking valve. Wholly artificial valves, i.e., mechanical valves, have also been developed to replace failing valves. Like the animal-based replacement valves, most artificial valves have leaflets mimicking native valves mounted in a frame that is implanted in the heart.
Although native mitral valves MV and tricuspid valves TV are irregularly shaped (i.e., non-circular) as shown in
Although some replacement valves are less susceptible to leakage when distorted, surgeons often must alter the surrounding tissue to match the configuration of the replacement valve to prevent leakage between the tissue and the replacement valve. These alterations introduce many of the same problems discussed above. Thus, there is a need for a replacement valve that is sized to correspond to the particular patient's heart, so surgeons need not alter surrounding heart tissue and restrict flow area.
As many as half of mitral valve replacement currently are performed using conventional surgery during which a patient's chest be opened and heart is bypassed while implanting the valve. These procedures are invasive and surgically traumatic, increasing recovery time and potential for fatality, particularly with older patients, which are most likely to need mitral valve replacement. Another procedure currently being investigated involves making smaller incisions into the chest cavity and through heart muscle into a patient's left ventricle to insert a catheter that delivers a replacement valve (e.g., a Tendyne mitral replacement valve available from Abbott Laboratories Medical Device Company). The valve opens inside the left atrium before being tethered to the heart muscle where the valve entered the left ventricle. This procedure potentially increases left ventricular loading, obstructs left ventricular outflow, causes blood loss, and other problems. Although the transcatheter replacement valve may be less invasive and reduce surgical trauma compared to conventional surgery, the valve does not minimize these problems and potentially introduces others.
In one aspect, the present disclosure includes a method of constructing a replacement valve for repairing a patient's failing heart valve. The failing valve has an annulus separating an upstream region from a downstream region. The method includes obtaining a representative inner perimetrical length of the annulus. A frame having a central hub and a plurality of flexibly resilient legs extending radially outward from the central hub is fabricated. Each leg extends to an anchor axially offset from the central hub by a preselected distance. Another step of the method includes fashioning an annular band having an outer circumferential length corresponding to the representative inner perimetrical length of the annulus. The band is attached to at least a portion of the plurality of legs of the frame adjacent to the respective anchors to limit spacing between the respective anchors of adjacent legs. A flexible valve component having a convex face and a concave face opposite the convex face is formed. The convex face has an annular margin and a central region axially offset from the annular margin. The central region of the convex face is connected to the central hub of the frame and circumferentially spaced portions of the annular margin are connected to at least one of the band and a portion of the frame adjacent to the anchors. The valve component is adapted to move when repairing the patient's failing heart valve in response to a difference between fluid pressure in the upstream region and fluid pressure in the downstream region. The valve component moves relative to the band between an open position in which the valve component permits downstream flow between the band and the annular margin of the valve component and a closed position in which the valve component blocks upstream flow between the band and the annular margin of the valve component. The valve component moves to the open position when fluid pressure in the upstream region is greater than fluid pressure in the downstream region to permit downstream flow from the upstream region to the downstream region. And the valve component moves to the closed position when fluid pressure in the downstream region is greater than fluid pressure in the upstream region to prevent flow reversal from the downstream region to the upstream region.
In another aspect, the present disclosure involves a method of performing a medical activity to repair a patient's failing heart having an annulus separating an upstream region from a downstream region. The method comprises the step of performing intracardiac echocardiography to measure a representative inner perimetrical length of the annulus. Further, the method includes the step of constructing a replacement valve. The replacement valve is constructed by fabricating a frame having a central hub and a plurality of flexibly resilient legs extending radially outward from the central hub. Each leg of the plurality of legs extends to an anchor axially offset from by a preselected distance the central hub. Another step of the method includes fashioning an annular band having a circumferential length corresponding to the representative inner perimetrical length of the annulus. The method also includes attaching the band to at least a portion of the plurality of legs of the frame adjacent to the respective anchors to limit spacing between the respective anchors of adjacent legs of the plurality of legs. A flexible valve component having a convex face and a concave face opposite the convex face is formed. The convex face has an annular edge margin and a central region axially offset from the edge margin. Moreover, the central region of the convex face is connected to the central hub of the frame and portions of the edge margin to at least one of the band and a portion of the frame adjacent to the anchors. The valve component is substantially free of connections to the frame other than the central hub and adjacent to the anchors. The valve component is adapted to move when repairing the patient's failing heart valve in response to a difference between fluid pressure in the upstream region and fluid pressure in the downstream region. The valve components move relative to the band between an open position in which the valve component permits downstream flow between the band and the edge margin of the valve component and a closed position in which the valve component blocks upstream flow between the band and the edge margin of the valve component. The valve component moves to the open position when fluid pressure in the upstream region is greater than fluid pressure in the downstream region to permit downstream flow from the upstream region to the downstream region. The valve component moves to the closed position when fluid pressure in the downstream region is greater than fluid pressure in the upstream region to prevent flow reversal from the downstream region to the upstream region. The method further comprises performing heart surgery to implant the constructed replacement valve in the patient's failing heart with the annular band of the replacement valve aligned with the measured annulus separating the upstream region from the downstream region and the flexible valve component oriented so the valve component moves to the open position when fluid pressure in the upstream region is greater than fluid pressure in the downstream region and the valve component moves to the closed position when fluid pressure in the downstream region is greater than fluid pressure in the upstream region.
In yet another aspect, the present disclosure includes a method of constructing a replacement valve for repairing a patient's failing heart valve having an annulus separating an upstream region from a downstream region that has a known representative inner perimetrical length. The replacement valve is constructed by fabricating a frame having a central hub and a plurality of flexibly resilient legs extending radially outward from the central hub. Each leg of the plurality of legs extends to an anchor axially offset from by a preselected distance the central hub. An annular band having a circumferential length corresponding to the representative inner perimetrical length of the annulus is fashioned. The method also includes attaching the band to at least a portion of the plurality of legs of the frame adjacent to the respective anchors to limit spacing between the respective anchors of adjacent legs of the plurality of legs. A flexible valve component having a convex face and a concave face opposite the convex face is formed. The convex face has an annular edge margin and a central region axially offset from the edge margin. Moreover, the central region of the convex face is connected to the central hub of the frame and portions of the edge margin to at least one of the band and a portion of the frame adjacent to the anchors. The valve component is substantially free of connections to the frame other than the central hub and adjacent to the anchors. The valve component is adapted to move when repairing the patient's failing heart valve in response to a difference between fluid pressure in the upstream region and fluid pressure in the downstream region. The valve components move relative to the band between an open position in which the valve component permits downstream flow between the band and the edge margin of the valve component and a closed position in which the valve component blocks upstream flow between the band and the edge margin of the valve component. The valve component moves to the open position when fluid pressure in the upstream region is greater than fluid pressure in the downstream region to permit downstream flow from the upstream region to the downstream region. The valve component moves to the closed position when fluid pressure in the downstream region is greater than fluid pressure in the upstream region to prevent flow reversal from the downstream region to the upstream region.
Other aspects of the disclosure will be apparent in view of the following description, including claims and drawings.
Corresponding reference characters indicate corresponding parts throughout the drawings.
As illustrated in
It is envisioned that each anchor 28 may taper from a width of about 3 mm to a width of about 2 mm or less, allowing the anchor to penetrate tissue in the heart more easily when being implanted. Further, each anchor 28 is angled perpendicular to the centerline C or angled upstream (i.e., in a direction corresponding to the arrow U in
As further illustrated in
Although the band 40 may have other constructions, the illustrated band has an annular inner strip 42 positioned inside the legs 26 and an annular outer strip 44 surrounding the legs so the inner strip and outer strip are joined in face-to-face relation and the legs are sandwiched between the inner and outer strips as illustrated in
The illustrated inner strip 42 comprises a non-porous woven Dacron® polyester to provide a smooth surface for reducing surface friction and to enhance sealing properties, and the illustrated outer strip 44 is a porous knit Dacron® polyester to promote vascularization and tissue ingrowth into the band for enhancing stability of the valve 10 after being implanted. (Dacron is a U.S. federally registered trademark owned by Invista North America, LLC of Wichita, Kans.) It is also envisioned that the band 40 may comprises other suitable materials such as heterologous animal pericardium (e.g., bovine or porcine pericardium), autologous tissue engineered substrates, or a biocompatible, radiopaque, elastic material, such as silicone rubber, polyurethane, or polytetrafluoroethylene (PTFE).
As shown in
The upstream side 52 of the flexible valve component 50 has an apex 58 that is attached to the downstream face of the frame 20 at the central hub 30. Although the valve component may be attached to the frame 20 by other means, the illustrated valve component 50 is attached to the frame by adhesive bonding. Further, the flexible valve component 50 is attached to the frame 20, and more specifically to the band 40, at several attachment points 60 around the frame. In the illustrated example, the valve component 50 is attached to the band 40 at three generally equally spaced locations around the band. Thus, the valve component 50 forms flaps 62 extending between adjacent attachment points 60. Each of the flaps 62 and a corresponding portion of the band 40 extending between adjacent attachment points 58 define one of the openings 56 through the valve when the valve component 50 moves to the open position, with the flaps of the valve component pushed inward toward the centerline C. Although the valve component may be attached to the band 40 by other means such as thermal bonding, ultrasonic bonding, laser enhanced bonding, and sewing, the illustrated valve component 50 is attached to the band by adhesive bonding.
Before making a replacement valve 10 for a particular patient's failing heart valve, a perimetrical length of a portion of the patient's heart must be measured. It is envisioned that the failing valve may be a native heart valve or a previously implanted replacement valve. Although the failing valve may correspond to a pulmonary valve PV or an aortic valve AV, in most instances it is envisioned the valve will be a mitral valve MV or a tricuspid valve TV. Accordingly, the required measurement will be described with respect the mitral valve and the tricuspid valve. Each of these valves separates an upstream region from a downstream region. For example, a mitral valve MV separates a left atrium LA (broadly, an upstream region) from a left ventricle LV (broadly, a downstream region). The mitral valve MV extends inward from tissue separating the upstream region from the downstream region. In cases where the replacement valve will be replacing a native mitral valve MV, a surgeon may prefer to leave the failing mitral valve leaflets intact. The required measurement will be an inner perimetrical length of an annulus including the tissue surrounding the mitral valve and the leaflets of the mitral valve MV fully opened against the tissue. In cases where the surgeon opts to remove the leaflets before implanting the replacement valve, the required measurement will be an inner perimetrical length of an annulus of heart tissue remaining after the leaflets are removed. In cases where the valve will be replacing a previously implanted replacement valve, the required measurement will be an inner perimetrical length of the frame of the previously implanted replacement valve with the valve elements (e.g., leaves) fully opened or removed as the surgeon prefers. From these examples, it is believed one skilled in the art will be able to determine which annulus should be measured to determine a corresponding inner perimetrical length. It is envisioned that any suitable procedure may be used to estimate the perimetrical length of the appropriate annulus. In one example, the patient's heart is imaged using intracardiac echocardiography (ICE). A two-dimensional planimetric analysis is performed using the resulting image to determine the nominal perimetrical length for the particular heart valve being replaced (e.g., the mitral valve MV or tricuspid valve TV). One benefit of using the planimetric analysis is that the two-dimensional analysis disregards three-dimensional variations that may be present in the ICE image so the fabricated heart valve 10 is appropriately sized to avoid leaks around the valve when implanted.
Once the perimetrical length of the annulus is determined, a skilled technician will be capable of making the replacement valve 10 for the particular failing heart valve. The frame 20 is fabricated using conventional methods such as those described above. Each frame element 22 is selected such that its size and shape will not interfere with operation of the upstream chamber. Once the frame 20 is fabricated, the annular band 40 may be fashioned by forming an annular outer strip 44 having an outer circumferential length equal to the representative inner perimetrical length of the failing valve annulus previously measured. The outer strip 44 is positioned around the legs 26 of the frame 20 adjacent to the anchors 28. The inner strip 42 is formed so its outer circumferential length corresponds to the inside surface of the outer strip 44 and the legs 26. The inner and outer strips 42, 44, respectively, are joined in face-to-face relation and to the frame 20 as described previously. The flexible valve component 50 is formed as previously discussed so that the component has an upstream side 42 and a downstream side 44. The apex 58 of the upstream side 42 is attached to the downstream face of the frame 20 at the central hub 30, and downstream points 60 on the convex side 42 of the component 50 are attached to corresponding points on the inner surface of the inner strip 42. Once the technician makes the valve 10, which is custom sized for the particular failing heart valve, the replacement valve may be implanted in the heart H using a suitable procedure. Such procedures are within the ordinary skill of practitioners in the art.
When introducing elements in the present written disclosure and appended claims, the articles “a”, “an”, “the”, and “said” should be interpreted as meaning there are one or more of the elements. The terms “comprising”, “including”, and “having” are intended to be inclusive and should be interpreted as meaning there may be additional elements other than those named.
As various changes could be made in the disclosed constructions, methods, and procedures without departing from the scope of the disclosure, it is intended that all matter contained in the description or shown in the accompanying drawings should be interpreted as illustrative and not in a limiting sense. It should be understood that modifications and variations in the constructions, method, and procedures that fall within the scope of the claims should be interpreted as part of the scope of the invention and as not departing from the scope of the invention.
Unless otherwise expressly stated, it is in no way intended that any method or aspect set forth herein be construed as requiring its steps be performed in a specific order. This construction holds for possible non-express bases for interpretation, including matters of logic with respect to arrangement of steps or operational flow, or plain meaning derived from grammatical organization or punctuation.
Insofar as the written description, the claims, and the accompanying drawings disclose additional subject matter that is not deemed to fall within the scope of the claims, the subject matter is expressly not dedicated to the public and the right to file other applications to claim the subject matter is reserved.
As those skilled in the art could make various changes to the above constructions, products, and methods without departing from the intended scope of the description, all matter in the above description and accompanying drawings should be interpreted as illustrative and not in a limiting sense.
Applicant claims the benefit of the co-pending U.S. Provisional Patent Application No. 63/215,443, entitled, “INTRACARDIAC-ECHOCARDIOGRAPHY-BASED MITRAL AND TRICUSPID REPLACEMENT VALVE”, filed on Jun. 26, 2021, which is hereby incorporated by reference in its entirety.
Number | Date | Country | |
---|---|---|---|
63215443 | Jun 2021 | US |